AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022
Nov 17, 2022
35599_dirs_2022-11-17_b37b00ca-e1fa-4af7-b1cd-bf07c408dce3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-11-17
Reporting Person: RALLIS CHRIS A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-17 | Common Shares | S | 333 | $7.99 | Disposed | 30018 | Direct |
Footnotes
F1: Represents shares sold pursuant to a 10b5-1 plan on November 17, 2022.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20